Overview

* Crescita Q3 2025 revenue rose 50% yr/yr, driven by Manufacturing segment growth

* Company swung from a net loss to a net income of C$753, reflecting strong performance

* Crescita repurchased 253,594 shares under NCIB, indicating financial confidence

Outlook

* Crescita expects increased recurring revenue from a new 5-year supply agreement

* Company exploring new partnerships for Pliaglis commercialization in various markets

Result Drivers

* MANUFACTURING GROWTH - Co attributes revenue increase to significant order fulfillment and production volume ramp-up in Manufacturing segment

* ASSET ACQUISITION - Acquisition of LPC assets, including Bacti Control brand, enhances recurring revenue and manufacturing capabilities

* SUPPLY AGREEMENT - New five-year exclusive supply agreement strengthens Manufacturing segment with stable recurring revenues

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 C$5.39

Revenue mln

Q3 C$262,00

Adjusted 0

EBITDA

Q3 Gross 52.90%

Margin

Q3 C$3.01

Operatin mln

g

Expenses

Q3 -C$162,0

Operatin 00

g Income

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)